Fig. 4.
Fig. 4. EPO and IL-3 activate the formation of Cbl/CrkII complexes. DA-3-EPO-R cells were depleted of cytokine for 8 hours and stimulated with no factor (lanes 6 and 12), 50 U/mL of murine IL-3 (lanes 1-5 and 13) or 50 U/mL of human EPO (lanes 7-11 and 14) for various periods of time as shown. Following cell lysis, an immunoprecipitation was performed with a CrkII polyclonal antibody. Lysate controls from 15 minute stimulations are shown in lanes 12-14. Immune complexes were resolved by SDS-PAGE and blotted to nitrocellulose. The immunoblot was probed with 4G10 monoclonal anti-phosphotyrosine antibody followed by HRP-Sheep antimouse IgG. The blot was then stripped and reprobed with either Cbl or CrkII polyclonal antibodies. Molecular mass standards are indicated.

EPO and IL-3 activate the formation of Cbl/CrkII complexes. DA-3-EPO-R cells were depleted of cytokine for 8 hours and stimulated with no factor (lanes 6 and 12), 50 U/mL of murine IL-3 (lanes 1-5 and 13) or 50 U/mL of human EPO (lanes 7-11 and 14) for various periods of time as shown. Following cell lysis, an immunoprecipitation was performed with a CrkII polyclonal antibody. Lysate controls from 15 minute stimulations are shown in lanes 12-14. Immune complexes were resolved by SDS-PAGE and blotted to nitrocellulose. The immunoblot was probed with 4G10 monoclonal anti-phosphotyrosine antibody followed by HRP-Sheep antimouse IgG. The blot was then stripped and reprobed with either Cbl or CrkII polyclonal antibodies. Molecular mass standards are indicated.

Close Modal

or Create an Account

Close Modal
Close Modal